Anesthesia and Critical Care Registry
Launched by UNIVERSITÀ VITA-SALUTE SAN RAFFAELE · Sep 4, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Anesthesia and Critical Care Registry, is designed to collect important information about patients who are receiving anesthesia or intensive care at our facility. The goal is to gather data from around 300,000 patients to help researchers improve how we care for individuals undergoing these procedures. By tracking the experiences and outcomes of patients, the study aims to identify ways to enhance treatment methods and ensure safer, more effective care for everyone.
To participate in this study, individuals must be undergoing anesthesia or receiving critical care and must provide signed consent to take part. Unfortunately, those who do not agree to participate will be excluded. Participants can expect that their information will be recorded and analyzed to contribute to future improvements in patient care. This study is open to all adults, regardless of gender, and aims to advance our understanding of anesthesia and critical care practices.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing Anesthesia or Critical care
- • Signed informed consent.
- Exclusion Criteria:
- • Refused informed consent
About Università Vita Salute San Raffaele
Università Vita-Salute San Raffaele is a prestigious Italian academic institution renowned for its commitment to advancing healthcare through innovative research and education. Located in Milan, it integrates cutting-edge scientific inquiry with clinical practice, fostering interdisciplinary collaboration among healthcare professionals. The university is dedicated to improving patient outcomes and public health by conducting rigorous clinical trials that adhere to the highest ethical standards. Its focus spans various medical fields, leveraging state-of-the-art facilities and a strong network of partnerships to drive advancements in medical science and contribute to the global healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, Mi, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported